The first rural hospital to line up for the life of the new government

Published Date: 08 Mar 2023

Hospitals in New Mexico, Texas and Oklahoma are the first to call for a new rural hospital payment model that shifts services from inpatients to outpatients and emergency patients.

Read Full News

Latest News

'Golden Hour' Rarely Achieved in Rural Trauma Care

Patients with trauma in rural areas travel nearly 190 miles and wait over 7 hours for definitive care, far exceeding the 'golden hour', as per a 10-year Montana study.

Vascular Cognitive Impairment and Dementia

This state of the art review describes the clinical features, pathophysiology, and biomarkers of vascular cognitive impairment and dementia for cardiovascular clinicians.

Impact of Environmental Allergens on Asthma Varies With Age

Older adults may be more vulnerable to asthma, study suggests.

Lymphoma Tx Linked to Mild Photodistributed Skin Reactions

About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly photodistributed erythematous patches, a study finds.

EMA Supports First European Therapy for WHIM Syndrome

WHIM syndrome is an ultra-rare hereditary immunodeficiency disease that leads to recurrent severe infections and an increased risk for viral-associated cancer.

Study Backs Longer Compounded Lido Plus Epi Shelf Life

Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration.

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Todays Updates

Immunotherapy Remains Little Used in Head and Neck Cancer

Immune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.

EVP Beats Cisplatin for Resectable MIBC

As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.

Latest News

Patients with trauma in rural areas travel nearly 190 miles and wait over 7 hours for definitive care, far exceeding the 'golden hour', as per a 10-year Montana study.

This state of the art review describes the clinical features, pathophysiology, and biomarkers of vascular cognitive impairment and dementia for cardiovascular clinicians.

Older adults may be more vulnerable to asthma, study suggests.

About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly photodistributed erythematous patches, a study finds.

WHIM syndrome is an ultra-rare hereditary immunodeficiency disease that leads to recurrent severe infections and an increased risk for viral-associated cancer.

Research supports the safety and efficacy of compounded lidocaine plus epinephrine for up to 24 hours at room temperature and up to 7 days with refrigeration.

News All Time

Earlier Mepolizumab in EGPA May Raise Remission Rate

Initiating mepolizumab within 3 months of EGPA diagnosis is associated with a higher remission rate, earlier glucocorticoid withdrawal, and less damage accrual.

Dupilumab Approved for Allergic Fungal Rhinosinusitis

The FDA has approved dupilumab to treat allergic fungal rhinosinusitis in adults and children ages 6 years and older.

Skin Infections Common in Border Camps

Dermatologic diseases, particularly infections and inflammatory conditions, frequently affect displaced persons at Mexico-US border camps, especially children, according to an analysis.

Heat-Related Emergency Calls Vary by Region and Age

Heat-related emergency medical service activations increased in the US from 2019 to 2024, but overall emergency demand grew faster, with regional and income disparities shaping risk, a study shows.

Fewer Newborns Receive Hepatitis B Vaccination

New data show newborn hepatitis B vaccination rates have dropped, raising concern over rising misinformation.

Dry Eye Disease May Occur Years Before Autoimmune Disease

Dry eye disease affects many people across different autoimmune diseases, ranging in prevalence from about 23% to 81%, and appears about 3 years before diagnosis, a study finds.

US FDA Commissioner Makary Says FDA Supports mRNA Vaccines but US Taxpayers Should Not Bear the Cost

U.S. Food and Drug Administration Commissioner Marty Makary on Monday defended his agency's position and record on mRNA vaccines, days after it changed course and agreed to...

NIH Denies Renewal of NIAMS Director’s Contract

Criswell will reportedly stay on as an intramural scientist, continuing to investigate genetic causes of autoimmune diseases.

Omalizumab Appears Superior to Dupilumab in Urticaria

Omalizumab shows superior efficacy to dupilumab in reducing symptoms in patients with chronic spontaneous urticaria.

Brief Program Improves QoL in Patients With Severe Allergies

Small gains in self-efficacy and injectable epinephrine prescription use were measured.

Flu Shot May Boost Survival in Patients With Cancer on ICIs

Patients with advanced cancer receiving influenza vaccination during immunotherapy had longer survival in a Swedish study, with no increase in immune-related toxicities.

Measles Cases in South Carolina Rise by 11 to 973

Measles cases in South Carolina surged to 973 on Friday, state ⁠health data showed, including 11 additional infections since Tuesday.

Going Home: Discharge Tips for CMC Patients

The number of children with medical complexity is growing and an efficient discharge requires a team approach. Here is how to make the transition successful.

Epinephrine Nasal Spray Promising for Urticaria Flares

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than the placebo group.

Pediatric Rheum Survey Shows Need to Improve Vaccine Reviews

A consensus statement with more specific guidance on communication practices may help standardize approaches to vaccine-related communication with families, author says.

Novel Combination Therapy: Breakthrough in Brain Metastases?

The combination of stereotactic RT or radiosurgery with immunotherapy or targeted therapy shows manageable toxicity and improved local control and clinical benefit in patients with brain metastases.

Recommended News For You

Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation

A study has developed molecular markers that predict meningioma recurrence.

Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.

Outcomes in Resected Melanoma Influenced by Timing of Recurrence

How a new light-based cancer treatment could destroy tumors without harming healthy cells—using LEDs

Charles III, King of Kings, is Cancerous.

Higher levels of HIF2α found to slow down aggressive childhood cancer

Recommended Articles For You

Debunking Myths About Systemic Mastocytosis: Separating Fact from Fiction  

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine 

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025 

Unlocking the Secrets of Neutrophils: Exploring Their Role in Immune Defense 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

2.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

3.

Research identifies nearly 200 potential breast carcinogens in food packaging materials

4.

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

5.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

1.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

2.

Uncovering the Hidden Symptoms of Parathyroid Cancer in Women

3.

Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications

4.

The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease 

5.

Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Understanding the causes of anemia in adults beyond nutritional deficiencies

2.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

3.

Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion

4.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot